Effect of drugs on red cell fragility.
D000109:Acetylcholine / Q000494:pharmacology*; D000654:Amobarbital / Q000494:pharmacology; D000661:Amphetamine / Q000494:pharmacology*; D001285:Atropine / Q000494:pharmacology*; D001463:Barbiturates / Q000494:pharmacology*; D001534:Bemegride / Q000494:pharmacology*; D002462:Cell Membrane / Q000187:drug effects; D002746:Chlorpromazine / Q000494:pharmacology*; D004837:Epinephrine / Q000494:pharmacology*; D004912:Erythrocytes / Q000187:drug effects; D006461:Hemolysis; D006591:Hexobarbital / Q000494:pharmacology; D009638:Norepinephrine / Q000494:pharmacology*; D009996:Osmotic Fragility / Q000187:drug effects*; D010424:Pentobarbital / Q000494:pharmacology; D010646:Phentolamine / Q000494:pharmacology*; D010830:Physostigmine / Q000494:pharmacology*; D012601:Scopolamine / Q000494:pharmacology*; D013874:Thiopental / Q000494:pharmacology
D001463:Barbiturates; D001534:Bemegride; D001285:Atropine; D010830:Physostigmine; D006591:Hexobarbital; D000661:Amphetamine; D012601:Scopolamine; D000654:Amobarbital; D010424:Pentobarbital; D013874:Thiopental; D000109:Acetylcholine; D002746:Chlorpromazine; D009638:Norepinephrine; D004837:Epinephrine; D010646:Phentolamine